Abstract
Purpose
There has been increasing interest in a risk-adopted management strategy known as dynamic risk stratification following the revised American Thyroid Association guidelines for differentiated thyroid cancer. We aimed to evaluate the usefulness of dynamic risk stratification for predicting structural disease in pediatric differentiated thyroid cancer patients.
Methods
We retrospectively reviewed 130 pediatric differentiated thyroid cancer patients (≤19 years) who were treated between 1996 and 2015 at Samsung Medical Center. Patients were stratified according to three American Thyroid Association initial risk group (low, intermediate, or high risk) and four dynamic risk stratification group (excellent, indeterminate, biochemical incomplete, or structural incomplete).
Results
Based on dynamic risk stratification strategy, structural disease was identified 3.9% in the excellent group, 9.7% in the indeterminate group, 76.9% in the biochemical incomplete group, and 100% in the structural incomplete group. The hazard ratios of the structural disease were 18.10 (P < 0.001) in the biochemical incomplete group, and 19.583 (P < 0.001) in the structural incomplete group compared to the excellent group. The prevalence of structural disease also increased as American Thyroid Association initial risk classification increased (5.9% in the low-risk group, 13.6% in the intermediate-risk group, and 45% in the high-risk group). The hazard ratios of structural disease in the high-risk group was 10.296 (P < 0.001) in compared to the low-risk group.
Conclusion
Dynamic risk stratification based on patient responses to initial therapy was able to effectively predict the risk of structural disease in a pediatric population, and as a follow-up strategy, may work as well in pediatric differentiated thyroid cancer patients as it does in adult differentiated thyroid cancer patients.
Similar content being viewed by others
References
E.K. Moon, H.J. Park, C.M. Oh, K.W. Jung, H.Y. Shin, B.K. Park, Y.J. Won, Cancer incidence and survival among adolescents and young adults in Korea. PLoS One 9(5), e96088 (2014). doi:10.1371/journal.pone.0096088
D.A. Siegel, J. King, E. Tai, N. Buchanan, U.A. Ajani, J. Li, Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics 134(4), e945–e955 (2014). doi:10.1542/peds.2013-3926
R.J. McNally, K. Blakey, P.W. James, B. Gomez Pozo, N.O. Basta, J. Hale, Increasing incidence of thyroid cancer in Great Britain, 1976–2005: age-period-cohort analysis. Eur. J. Epidemiol. 27(8), 615–622 (2012). doi:10.1007/s10654-012-9710-x
Y.Y. Cho, H.W. Jang, J.Y. Joung, S.M. Park, D.J. Jeong, S.W. Kim, J.H. Chung, Trends in thyroid cancer incidence in Korean children (1999–2012) Based on palpation and nonpalpation detection methods. Eur. Thyroid J. 4(4), 252–259 (2015). doi:10.1159/000442047
K. Czene, P. Lichtenstein, K. Hemminki, Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int. J. Cancer 99(2), 260–266 (2002). doi:10.1002/ijc.10332
E.D. Williams, I. Doniach, O. Bjarnason, W. Michie, Thyroid cancer in an iodide rich area: a histopathological study. Cancer 39(1), 215–222 (1977)
M.S. Klein Hesselink, M. Nies, G. Bocca, A.H. Brouwers, J.G. Burgerhof, E.W. van Dam, B. Havekes, M.M. van den Heuvel-Eibrink, E.P. Corssmit, L.C. Kremer, R.T. Netea-Maier, H.J. van der Pal, R.P. Peeters, K.W. Schmid, J.W. Smit, G.R. Williams, J.T. Plukker, C.M. Ronckers, H.M. van Santen, W.J. Tissing, T.P. Links, Pediatric differentiated thyroid carcinoma in The Netherlands: a nationwide follow-up study. J. Clin. Endocrinol. Metab. 101(5), 2031–2039 (2016). doi:10.1210/jc.2015-3290
J.S. Brink, J.A. van Heerden, B. McIver, D.R. Salomao, D.R. Farley, C.S. Grant, G.B. Thompson, D. Zimmerman, I.D. Hay, Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 128(6), 881–886; discussion 886–887 (2000). doi:10.1067/msy.2000.109728.
S.A. Rivkees, E.L. Mazzaferri, F.A. Verburg, C. Reiners, M. Luster, C.K. Breuer, C.A. Dinauer, R. Udelsman, The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr. Rev. 32(6), 798–826 (2011). doi:10.1210/er.2011-0011
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). doi:10.1089/thy.2015.0020
D.P. Momesso, F. Vaisman, S.P. Yang, D.A. Bulzico, R. Corbo, M. Vaisman, R.M. Tuttle, Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J. Clin. Endocrinol. Metab. 101(7), 2692–2700 (2016). doi:10.1210/jc.2015-4290
G.L. Francis, S.G. Waguespack, A.J. Bauer, P. Angelos, S. Benvenga, J.M. Cerutti, C.A. Dinauer, J. Hamilton, I.D. Hay, M. Luster, M.T. Parisi, M. Rachmiel, G.B. Thompson, S. Yamashita; American Thyroid Association Guidelines Task, F., Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25(7), 716–759 (2015). doi:10.1089/thy.2014.0460
R.M. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein, M. Gonen, M. Brokhin, G. Omry, J.A. Fagin, A. Shaha, Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20(12), 1341–1349 (2010). doi:10.1089/thy.2010.0178
L. Lazar, Y. Lebenthal, K. Segal, A. Steinmetz, Y. Strenov, M. Cohen, I. Yaniv, M. Yackobovitch-Gavan, M. Phillip, Pediatric thyroid cancer: postoperative classifications and response to initial therapy as prognostic factors. J. Clin. Endocrinol. Metab. 101(5), 1970–1979 (2016). doi:10.1210/jc.2015-3960
T.Y. Sung, M.J. Jeon, Y.H. Lee, Y.M. Lee, H. Kwon, J.H. Yoon, K.W. Chung, W.G. Kim, D.E. Song, S.J. Hong, Initial and dynamic risk stratification of pediatric patients with differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 102(3), 793–800 (2017). doi:10.1210/jc.2016-2666
F. Vaisman, H. Tala, R. Grewal, R.M. Tuttle, In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21(12), 1317–1322 (2011). doi:10.1089/thy.2011.0232
M.J. Jeon, W.G. Kim, W.R. Park, J.M. Han, T.Y. Kim, D.E. Song, K.W. Chung, J.S. Ryu, S.J. Hong, Y.K. Shong, W.B. Kim, Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma. Eur. J. Endocrinol. 170(1), 23–30 (2014). doi:10.1530/EJE-13-0524
A. Cano-Palomares, I. Castells, I. Capel, M.R. Bella, S. Barcons, A. Serrano, X. Guirao, M. Rigla, Response to initial therapy of differentiated thyroid cancer predicts the long-term outcome better than classical risk stratification systems. Int J. Endocrinol. 2014, 591285 (2014). doi:10.1155/2014/591285
Y.A. Lee, H.W. Jung, H.Y. Kim, H. Choi, H.Y. Kim, J.H. Hah, D.J. Park, J.K. Chung, S.W. Yang, C.H. Shin, Y.J. Park, Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years. J. Clin. Endocrinol. Metab. 100(4), 1619–1629 (2015). doi:10.1210/jc.2014-3647
J. Mihailovic, K. Nikoletic, D. Srbovan, Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes. J. Nucl. Med. 55(5), 710–717 (2014). doi:10.2967/jnumed.113.130450
C.A. Welch Dinauer, R.M. Tuttle, D.K. Robie, D.R. McClellan, R.L. Svec, C. Adair, G.L. Francis, Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin. Endocrinol. 49, 619–628 (1998)
B.P. Pires, P.A. Alves Jr., M.A. Bordallo, D.A. Bulzico, F.P. Lopes, T. Farias, F. Dias, R.A. Lima, I.C. Santos Gisler, C.M. Coeli, R.V. Carvalhaes de Oliveira, R. Corbo, M. Vaisman, F. Vaisman, Prognostic factors for early and long-term remission in pediatric differentiated thyroid carcinoma: the role of sex, age, clinical presentation, and the newly proposed American thyroid association risk stratification system. Thyroid 26(10), 1480–1487 (2016). doi:10.1089/thy.2016.0302
P.A. Powers, C.A. Dinauer, R.M. Tuttle, G.L. Francis, The MACIS score predicts the clinical course of papillary thyroid carcinoma in children and adolescents. J. Pediatr. Endocrinol. Metab. 17, 339–343 (2004)
Y.Y. Cho, J. Lim, C.M. Oh, J. Ryu, K.W. Jung, J.H. Chung, Y.J. Won, S.W. Kim, Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea. Cancer 121(2), 259–268 (2015). doi:10.1002/cncr.29025
A.P. Brown, J. Chen, Y.J. Hitchcock, A. Szabo, D.C. Shrieve, J.D. Tward, The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 93(2), 504–515 (2008). doi:10.1210/jc.2007-1154
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Seo Young Sohn and Young Nam Kim contributed equally to this work.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Sohn, S.Y., Kim, Y.N., Kim, H.I. et al. Validation of dynamic risk stratification in pediatric differentiated thyroid cancer. Endocrine 58, 167–175 (2017). https://doi.org/10.1007/s12020-017-1381-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1381-7